These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28031926)

  • 1. Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease.
    Agrawal G; Borody T; Turner R; Leis S; Campbell J
    Future Sci OA; 2015 Nov; 1(4):FSO77. PubMed ID: 28031926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
    Borody TJ; Leis S; Warren EF; Surace R
    Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.
    Savarino E; Bertani L; Ceccarelli L; Bodini G; Zingone F; Buda A; Facchin S; Lorenzon G; Marchi S; Marabotto E; De Bortoli N; Savarino V; Costa F; Blandizzi C
    Expert Opin Biol Ther; 2019 Feb; 19(2):79-88. PubMed ID: 30574820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars.
    Borody TJ; Bilkey S; Wettstein AR; Leis S; Pang G; Tye S
    Dig Liver Dis; 2007 May; 39(5):438-44. PubMed ID: 17369114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
    Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
    Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remicade does not abolish the need for surgery in fistulizing Crohn's disease.
    Poritz LS; Rowe WA; Koltun WA
    Dis Colon Rectum; 2002 Jun; 45(6):771-5. PubMed ID: 12072629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine.
    Schröder O; Blumenstein I; Schulte-Bockholt A; Stein J
    Aliment Pharmacol Ther; 2004 Feb; 19(3):295-301. PubMed ID: 14984376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.
    Regueiro M; Mardini H
    Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab in treatment of Crohn's disease: the Milan experience.
    Ardizzone S; Colombo E; Maconi G; Bollani S; Manzionna G; Petrone MC; Bianchi Porro G
    Dig Liver Dis; 2002 Jun; 34(6):411-8. PubMed ID: 12132788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: Medical therapy for fistulizing Crohn's disease.
    Bressler B; Sands BE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: the efficacy of infliximab in Crohn's disease--healing of fistulae.
    Present DH
    Aliment Pharmacol Ther; 1999 Sep; 13 Suppl 4():23-8; discussion 38. PubMed ID: 10597336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of response to infliximab in patients with fistulizing Crohn's disease.
    Luna-Chadid M; Pérez Calle JL; Mendoza JL; Vera MI; Bermejo AF; Sánchez F; López San Román A; Froilán C; González-Lara V; García-Paredes J; Fernández-Blanco I; Abreu L; Casis B; Solís Herruzo JA; Gisbert JP; Maté Jiménez J
    Rev Esp Enferm Dig; 2004 Jun; 96(6):379-81; 382-4. PubMed ID: 15230667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperbaric oxygen in the treatment of perineal Crohn's disease era of infliximab: a renewal interest?].
    Bedioui H; Makni A; Magherbi H; Ben Safta Z
    Tunis Med; 2012 Jun; 90(6):427-30. PubMed ID: 22693080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Postinduction Infliximab Serum Trough Levels Are Associated With Healing of Fistulizing Perianal Crohn's Disease in Children.
    El-Matary W; Walters TD; Huynh HQ; deBruyn J; Mack DR; Jacobson K; Sherlock ME; Church P; Wine E; Carroll MW; Benchimol EI; Lawrence S; Griffiths AM
    Inflamm Bowel Dis; 2019 Jan; 25(1):150-155. PubMed ID: 29912413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperbaric Oxygen Therapy Achieved Fistula Healing in a Young Patient With Severe Refractory Perianal Crohn's Disease.
    Leong JWH; Yan ZH; Foo FJ; Koh FH; Cheng LT; Kong SC; Tey TT
    Cureus; 2024 Jun; 16(6):e62987. PubMed ID: 39050284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.